These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30287313)

  • 21. [Drug treatment of dermatological disorders. Aspects to consider from an andrological perspective].
    Grunewald S; Paasch U
    Hautarzt; 2015 Dec; 66(12):913-8. PubMed ID: 26452356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outdoor air pollution and sperm quality.
    Lafuente R; García-Blàquez N; Jacquemin B; Checa MA
    Fertil Steril; 2016 Sep; 106(4):880-96. PubMed ID: 27565259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Autoimmune Bullous Disorders in Pregnancy.
    Kushner CJ; Concha JSS; Werth VP
    Am J Clin Dermatol; 2018 Jun; 19(3):391-403. PubMed ID: 29392620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the teratogenicity of isotretinoin outweigh its benefits?
    Jordan AY; Parks L; Chen SC; Higgins K; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2005; 16(4):190-2. PubMed ID: 16249139
    [No Abstract]   [Full Text] [Related]  

  • 25. Finasteride and fertility: case report and review of the literature.
    Ricci G; Martinelli M; Luppi S; Lo Bello L; De Santis M; Skerk K; Zito G
    J Drugs Dermatol; 2012 Dec; 11(12):1511-3. PubMed ID: 23377525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caring for women with childbearing potential taking teratogenic dermatologic drugs. Guidelines for practice.
    Perlman SE; Rudy SJ; Pinto C; Townsend-Akpan C
    J Reprod Med; 2001 Feb; 46(2 Suppl):153-61. PubMed ID: 11255823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes.
    Yiu ZZ; Warren RB; Mrowietz U; Griffiths CE
    J Dermatolog Treat; 2015; 26(4):329-34. PubMed ID: 25424052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermatologic and nondermatologic uses of thalidomide.
    Nasca MR; Micali G; Cheigh NH; West LE; West DP
    Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we ensure the safe use of known human teratogens?: The iPLEDGE test case.
    Honein MA; Lindstrom JA; Kweder SL
    Drug Saf; 2007; 30(1):5-15. PubMed ID: 17194167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata.
    Sotoodian B; Kuzel P; Brassard A; Fiorillo L
    Cutis; 2017 Dec; 100(6):E23-E26. PubMed ID: 29360905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counselling regarding paternal exposures: Can we do better?
    Ritchie HE; Oakes DJ; Hegedus E; Hill M; Kennedy D
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):162-167. PubMed ID: 28276580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid.
    Brown SM; Aljefri K; Waas R; Hampton P
    J Dermatolog Treat; 2019 Feb; 30(1):2-18. PubMed ID: 28092212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
    JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced ocular side-effects with isotretinoin.
    Santodomingo-Rubido J; Barrado-Navascués E; Rubido-Crespo MJ
    Ophthalmic Physiol Opt; 2008 Sep; 28(5):497-501. PubMed ID: 18761487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
    De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A
    Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721
    [No Abstract]   [Full Text] [Related]  

  • 38. Time to pregnancy and paternal exposure to pesticides in preliminary results from Danish and French studies. Asclepios.
    Thonneau P; Larsen SB; Abell A; Clavert A; Bonde JP; Ducot B; Multigner L
    Scand J Work Environ Health; 1999; 25 Suppl 1():62-3; discussion 76-8. PubMed ID: 10235412
    [No Abstract]   [Full Text] [Related]  

  • 39. High-dose treatment with vitamin A analogues and risk of fractures.
    Vestergaard P; Rejnmark L; Mosekilde L
    Arch Dermatol; 2010 May; 146(5):478-82. PubMed ID: 20479294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide.
    Zeldis JB; Williams BA; Thomas SD; Elsayed ME
    Clin Ther; 1999 Feb; 21(2):319-30. PubMed ID: 10211535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.